Fundz

Ribometrix, Inc.

Greenville, North Carolina, United States · Healthcare

Ribometrix is a platform therapeutics company discovering small molecule drugs that target functional 3D RNA structures to treat human diseases. Our scientific offices are located in the newly renovated Biolabs Space in Durham, with offices in Chapel Hill and Boston.

Key facts

Headquarters
Greenville, North Carolina, United States
Employees
24
Industries
Healthcare
Status
Private
Website
ribometrix.com
LinkedIn
Company page

Recent activity at Ribometrix, Inc.

Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.

Ribometrix, Inc. funding history

DateRoundAmount
Nov 2018Venture$15.0M

Leadership

  • Katie Warner, Chief Scientific Officer
  • William S. Marshall, Chief Executive Officer

Verified email and direct lines for Ribometrix, Inc.’s decision-makers are on Fundz. See plans or book a 15-minute walkthrough.

Employee benefit plans

Ribometrix, Inc. files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.

Companies similar to Ribometrix, Inc.

About Ribometrix, Inc.: questions and answers

What does Ribometrix, Inc. do?

Ribometrix is a platform therapeutics company discovering small molecule drugs that target functional 3D RNA structures to treat human diseases. Our scientific offices are located in the newly renovated Biolabs Space in Durham, with offices in Chapel Hill and Boston.

Where is Ribometrix, Inc. headquartered?

Ribometrix, Inc. is headquartered in Greenville, North Carolina, United States.

How many employees does Ribometrix, Inc. have?

Ribometrix, Inc. has about 24 employees.

Has Ribometrix, Inc. raised funding?

Yes. Fundz has recorded 1 funding event for Ribometrix, Inc.. The most recent, $15.0M, was in Nov 2018.

Who leads Ribometrix, Inc.?

William S. Marshall is a Chief Executive Officer at Ribometrix, Inc..

What is the latest news on Ribometrix, Inc.?

On Jan 9, 2025, Ribometrix Appoints William S. Marshall, Ph.D., as Chief Executive Officer (CEO) and Katie Warner, Ph.D., as Chief Scientific Officer (CSO)

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches Ribometrix, Inc. across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.